课题基金 / 基金详情

NSFDEB-BSF: Collaborative Research: RUI: The fitness cost of every single mutation in the HIV genome

NSFDEB-BSF: Collaborative Research: RUI: The fitness cost of every single mutation in the HIV genome
NSFDEB-BSF:合作研究:RUI:HIV 基因组中每个单一突变的适应成本
批准号:
1655212
负责人:
Pleuni Pennings
金额:
$61.23万
依托单位国家:
美国
项目类别:
Standard Grant
财政年份:
2017
资助国家:
美国
项目状态:
已结题
起止时间:
2017-08-01 至 2023-07-31

项目摘要

项目成果

Pleuni Pennings的其他基金

相似基金

相关文献

中文摘要
翻译
这个合作项目涉及两名职业生涯早期的女性研究人员,一名来自美国,另一名来自以色列。他们的目标是使用新的实验室技术和新的统计方法来确定人类免疫缺陷病毒(HIV)基因组所有可能突变的适宜成本。突变是基因变异的最终来源,也是进化的燃料。但一个特定的突变是否会持续存在并导致种群内的变异,取决于它的适应成本。与那些健康成本很低或没有健康成本的突变相比,高健康成本的突变很可能会从人群中消除。突变适合度知识是进化生物学中许多基本问题的核心,但也具有关键的实际应用,例如,在预测抗生素、抗病毒药物和杀虫剂的耐药性进化方面。尽管这很重要,估计适应成本仍然是现代进化基因组学的关键挑战之一。研究人员将使用创新的基因组和计算方法分析75名艾滋病毒B亚型和C亚型患者的临床样本。由此产生的数据最终将使他们能够推断艾滋病毒基因组中每个单点突变的适应成本。该项目包括为STEM领域中代表性不足群体的本科生提供密集的指导和研究机会。这些学生还将获得国际经验。将开发一门新的研究生水平课程,内容是向公众传播科学。公众宣传将通过视频、公开讲座和访问当地学校进行。HIV是研究体内健康成本的理想模型系统:遗传多样性在每个宿主中迅速积累,来自不同患者的样本可以被视为独立的复制群体。然后,可以通过使用突变-选择平衡理论和平均患者的突变频率来推断健康成本。研究人员有三个主要目标。1)开发从突变频率推断适应度成本的统计方法。2)为低生物量样本开发高精度的下一代测序方法,并使用这些方法对患者样本中的HIV进行测序并推断突变频率。3)推断全球最流行的两个HIV-1亚型B和C亚型的健康成本高分辨率地图,并量化与背景相关的健康影响。实现这些目标将导致首次在体内完全分配基因组的适合性成本。这些创新方法的开发也将推广到任何存在独立种群的下一代测序(NGS)数据的系统。该奖项由国际科学与工程办公室共同资助。
英文摘要
This collaborative project involves two early career female researchers, one from the U.S. and the other from Israel. Their goal is to determine the fitness cost of all possible mutations in the human immunodeficiency virus (HIV) genome using new laboratory techniques and new statistical methods. Mutations are the ultimate source of genetic variation and the fuel of evolution. But whether a particular mutation persists and contributes to variation within a population is determined by its fitness cost. Mutations with high fitness costs will likely be eliminated from the population versus those with little or no fitness costs. Knowledge of mutational fitness is central to many basic questions in evolutionary biology, but also has critical practical application, for example, for predicting evolution of resistance to antibiotics, antiviral drugs, and pesticides. Despite this importance, estimating fitness costs remains one of the key challenges in modern evolutionary genomics. The researchers will analyze clinical samples from a combination of 75 HIV subtype B and subtype C patients using innovative genomic and computational methods. Resulting data will ultimately allow them to infer the fitness cost of every single point mutation in the HIV genome. The project includes intensive mentoring and research opportunities for undergraduate students from underrepresented groups in STEM fields. These students will also gain international experiences. A new graduate level course on communicating science to the public will be developed. Public outreach will occur via videos, public lectures, and visits to local schools. HIV is an ideal model system for studying in vivo fitness costs: Genetic diversity accumulates quickly in every host, and samples from different patients can be treated as independent replicate populations. Fitness costs can then be inferred by using the theory of mutation-selection balance and averaging mutation frequencies across patients. The researchers have three primary objectives. 1) Develop statistical methods for inferring fitness costs from mutation frequencies. 2) Develop highly accurate next generation sequencing approaches for low biomass samples, and use these to sequence HIV from patient samples and infer mutation frequencies. 3) Infer high-resolution maps of fitness costs in HIV-1 subtypes B and C, the two most prevalent subtypes across the globe, and quantify context-dependent fitness effects. Accomplishing these objectives will lead to the first complete in vivo distribution of fitness costs for a genome. Development of these innovative methods will also be generalizable to any system for which next generation sequencing (NGS) data exist for independent populations. This award is co-funded by the Office of International Science and Engineering.
期刊论文(8)
专著(0)
科研奖励(0)
会议论文
Inferring population genetics parameters of evolving viruses using time-series data
使用时间序列数据推断进化病毒的群体遗传学参数
DOI: 10.1093/ve/vez011
发表时间: 2019
期刊: Virus Evolution
影响因子: 5.3
作者: [Zinger, Tal, Gelbart, Maoz, Miller, Danielle, Pennings, Pleuni S, Stern, Adi]
通讯作者: Stern, Adi
Drug Resistance Evolution in HIV in the Late 1990s: Hard Sweeps, Soft Sweeps, Clonal Interference and the Accumulation of Drug Resistance Mutations
20 世纪 90 年代末 HIV 耐药性演变:硬扫描、软扫描、克隆干扰和耐药性突变的积累
DOI: 10.1534/g3.119.400772
发表时间: 2020
期刊: G3: Genes|Genomes|Genetics
影响因子: --
作者: [Williams, Kadie-Ann, Pennings, Pleuni]
通讯作者: Pennings, Pleuni
DOI: 10.1007/s10682-020-10039-z
发表时间: 2020-04-24
期刊: EVOLUTIONARY ECOLOGY
影响因子: 1.9
作者: [Caudill, Victoria R., Qin, Sarina, Pennings, Pleuni S.]
通讯作者: Pennings, Pleuni S.
IGE: Graduate Opportunities to Learn Data Science (GOLD): Empowering female and underrepresented graduate students through inclusive data science training
  • 批准号:
    1856394
  • 项目类别:
    Standard Grant
  • 资助金额:
    $50.0万
  • 财政年份:
    2019
  • 负责人:
    Pleuni Pennings
  • 依托单位:
国内基金
海外基金
枯草芽孢杆菌BSF01降解高效氯氰菊酯的种内群体感应机制研究
  • 批准号:
    31871988
  • 项目类别:
    面上项目
  • 资助金额:
    59.0万元
  • 批准年份:
    2018
  • 负责人:
    钟国华
  • 依托单位:
基于掺硼直拉单晶硅片的Al-BSF和PERC太阳电池光衰及其抑制的基础研究
  • 批准号:
    61774171
  • 项目类别:
    面上项目
  • 资助金额:
    63.0万元
  • 批准年份:
    2017
  • 负责人:
    艾斌
  • 依托单位:
B细胞刺激因子-2(BSF-2)与自身免疫病的关系
  • 批准号:
    38870708
  • 项目类别:
    面上项目
  • 资助金额:
    3.0万元
  • 批准年份:
    1988
  • 负责人:
    吴厚生
  • 依托单位: